| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972040 | The Journal of Heart and Lung Transplantation | 2009 | 7 Pages |
Abstract
Patients with PPI co-medication show significantly lower MPA plasma concentrations, possibly due to decreased absorption. Therapeutic drug monitoring allows identification of patients with decreased MMF drug exposure who might be at risk for acute rejection.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sieglinde MD, Marcus-André MD, Amir K. MD, Nataliya MD, Michael MD, Thomas H. MD, Bruno MD, Gerhard MD, Bruno MD, Ingo MD,